Next 10 |
MultiPlan Corporation (“MultiPlan” or the “Company”) (NYSE: MPLN), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, payment and revenue integrity solutions to the U.S. healthcare industry, announced today that it will ...
2024-03-29 16:39:00 ET More on Multiplan MultiPlan Corporation (MPLN) Q4 2023 Earnings Call Transcript MultiPlan Corporation 2023 Q4 - Results - Earnings Call Presentation MultiPlan appoints Jerry Hogge as COO Seeking Alpha’s Quant Rating on Multiplan ...
– Company has six months to regain compliance with the minimum price criteria for continued listing on the NYSE – Company remains focused on executing its Growth Plan and on delivering results and shareholder value MultiPlan Corporation (NYSE: MPLN) (“Mult...
2024-03-07 09:23:59 ET More on Multiplan MultiPlan Corporation (MPLN) Q4 2023 Earnings Call Transcript MultiPlan Corporation 2023 Q4 - Results - Earnings Call Presentation Seeking Alpha’s Quant Rating on Multiplan Historical earnings data for Multiplan...
Hogge’s Growth-Driven Expertise Bolsters MultiPlan’s Next Phase of Growth and Innovation MultiPlan Corporation (NYSE: MPLN) (“MultiPlan” or the “Company”), a leading value-added provider of data analytics and technology-enabled end-to-end cost m...
MultiPlan Corporation (NYSE:MPLN) (“MultiPlan” or the “Company”), a leading provider of technology and data-enabled end-to-end cost management, payment and revenue integrity solutions to the U.S. healthcare industry, today announced that members of its management team ...
As required by the rules of the New York Stock Exchange, MultiPlan Corporation (NYSE:MPLN) (“MultiPlan” or the “Company”) today announced that it has granted to Travis Dalton, the Company’s recently appointed President and Chief Executive Officer, on March 1, 20...
Evolv Technologies Holdings Inc. (EVLV) is expected to report $-0.14 for Q4 2023 The Lion Electric Company (LEV) is expected to report $-0.1 for Q4 2023 Fisker Inc. Class A (FSR) is expected to report $-0.2 for Q4 2023 Y-mAbs Therapeutics Inc. (YMAB) is expected to report $-0.19 for Q...
– Q4 2023 Revenues of $244.1 million, Net Loss of $31.4 million and Adjusted EBITDA of $156.8 million – Full Year 2023 Revenues of $961.5 million, Net Loss of $91.7 million and Adjusted EBITDA of $618.0 million – Identified potential medical cost savings of ...
MultiPlan Corporation (“MultiPlan” or the “Company”) (NYSE: MPLN), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, payment and revenue integrity solutions to the U.S. healthcare industry, announced today that it will ...
News, Short Squeeze, Breakout and More Instantly...
MultiPlan Corporation Class A Company Name:
MPLN Stock Symbol:
NYSE Market:
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, whic...
MultiPlan Corporation (“MultiPlan” or the “Company”) (NYSE: MPLN), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, payment and revenue integrity solutions to the U.S. healthcare industry, announced today that it will ...
– Company has six months to regain compliance with the minimum price criteria for continued listing on the NYSE – Company remains focused on executing its Growth Plan and on delivering results and shareholder value MultiPlan Corporation (NYSE: MPLN) (“Mult...